imipramine has been researched along with Liver Steatosis in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liangpunsakul, S | 1 |
| Rahmini, Y | 1 |
| Ross, RA | 1 |
| Zhao, Z | 1 |
| Xu, Y | 1 |
| Crabb, DW | 1 |
1 other study available for imipramine and Liver Steatosis
| Article | Year |
|---|---|
Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Ceramides; Enzyme Activation; Ethanol; Fatty | 2012 |